Active pharmaceutical analysis

MLC enables to analyse drugs and active phamiaceutical substances without using special column and lai ge quantity of organic solvents. So, from the point of view of pharmaceutical analysis ecology and green chemistry conception, assay with MLC using will be better than conventional reversed-phase chromatography. 

However, compared with the traditional analytical methods, the adoption of chromatographic methods represented a signihcant improvement in pharmaceutical analysis. This was because chromatographic methods had the advantages of method specihcity, the ability to separate and detect low-level impurities. Specihcity is especially important for methods intended for early-phase drug development when the chemical and physical properties of the active pharmaceutical ingredient (API) are not fully understood and the synthetic processes are not fully developed. Therefore the assurance of safety in clinical trials of an API relies heavily on the ability of analytical methods to detect and quantitate unknown impurities that may pose safety concerns. This task was not easily performed or simply could not be carried out by classic wet chemistry methods. Therefore, slowly, HPLC and GC established their places as the mainstream analytical methods in pharmaceutical analysis. 

Another potential benefit of UHPLC is its capability of solving the most challenging separation tasks in pharmaceutical analysis. Figure 9.4 shows a UPLC method developed to analyze pharmaceutical formulations used to treat the common cold. Cold products often contain multiple active ingredients to treat different symptoms and can contain decongestants, antihistamines, pain relievers, cough suppressants, expectorants, and numerous excipients of various polarities. The analysis of a total of 20 components was achieved within 10 min. 

FIA has also found wide application in pharmaceutical analysis.214,215 Direct UV detection of active ingredients is the most popular pharmaceutical analysis application of FIA. For single component analysis of samples with little matrix interference such as dissolution and content uniformity of conventional dosage forms, many pharmaceutical chemists simply replace a column with suitable tubing between the injector and the detector to run FIA on standard HPLC instrumentation. When direct UV detection offers inadequate selectivity, simple online reaction schemes with more specific reagents including chemical, photochemical, and enzymatic reactions of derivatization are applied for flow injection determination of pharmaceuticals.216... 

Fig. 17.13. Electropherograms obtained for the analysis of a nasal formulation for the determinations of benzalkonium chloride (BC) in the presence of active pharmaceutical ingredient (R91274) and other placebo ingredients. Conditions 75 mM sodium phosphate buffer, pH = 2.3, 35 cm fused silica capillary (effective length 28.5 cm) x 75 pm I.D., injection 10 s at 35mbar, 20°C, 15 kV (positive polarity) resulting in a current of approximately 95 pA, detection UV 215 nm.

This chapter reviews the underlying principles of ion chromatography and its application in pharmaceutical analysis. It provides an overview of eluent systems, applications of gradients, electrolytic eluent generation, suppressors, and stationary phases. Applications of ion chromatography to the confirmation of counter ions, active ingredient analysis, competitive analysis and development work are discussed. 

Reliable quality control in the field of pharmaceutical analysis is based on the use of valid analytical methods. For this reason, any analytical procedures proposed for a particular active pharmaceutical ingredient and its corresponding dosage forms shonld be validated to demonstrate that they are scientifically sonnd nnder the experimental conditions intended to be used. Since dissolntion data reflect drng prod-net stability and quality, the HPLC method used in snch tests shonld be validated in terms of accuracy, precision, sensitivity, specificity, rngged-ness, and robustness as per ICH guidelines. 

V. ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS AND DRUG PRODUCTS... 

Table 12 gives an orientation help for CE separations sorted by pharmaceutical substances published in review articles. As this chapter focuses on the technical development of drug substances and products, only drug substances and drug formulations are covered. A useful compendium of CE applications in the pharmaceutical environment can be found in the book Capillary Electrophoresis Methods for Pharmaceutical Analysis written by G. Lunn. The book covers more than 700 active pharmaceutical ingredients and contains short method descriptions, sample preparation steps, and references. 

Jamali, B., and Lehmann, S. (2004). Development and validation of a high-resolution capillary electrophoresis method for multi-analysis of ragaglitazar and arginine in active pharmaceutical ingredients and low-dose tablets. /. Pharm. Biomed. Anal. 34(3), 463—472. 

Micellar electrokinetic chromatography is applied for the analysis of a wide variety of organic substances, ionic and nonionic in nature. For instance, for the determination of the content of active pharmaceutical ingredients in tablets, creams, and injectables, the MEKC mode often offers advantages over the CZE mode. 

Active pharmaceutical ingredients (API) can be identified using many different analytical approaches. A Raman spectroscopy method may not be the most common or economical but it does offer significant advantages. These include rapid, sensitive analysis, information-rich spectra, minimal or no sampling [32]. Handheld Raman spectrometers now allow the measurement to be taken to samples allowing analysis at the point of receipt and not just in a... 

Endothelial cells 930 Entrapment 340, el52 Environmental 949 food and pharmaceutical analysis 358 monitoring 131 permanence e75, e77 Enzymatic activity 363 amplification 928 labelling e218... 

Quantitative and/or qualitative XRPD methods have been reported to determine the polymorphic content of clopidogrel bisulfate samples, and these have been summarized in Table 2.3. Koradia et al. [16] reported the qualitative analysis of clopidogrel bisulfate in both active pharmaceutical ingredients and tablet dosage forms. Based on the interplanar distances (d-spacing) associated with each polymorph, it was concluded that the molecular packing in Form-I was more dense than that of Form-II, indicating that Form-II would be less stable relative to Form-I. This result was similar with that reported by Bousquet [9]. 

Paulekuhn, G. S., Dressman, I. B., Saal, C. Trends in Active Pharmaceutical Ingredient Salt Selection Based on Analysis of the Orange Book Database. J. Med. Chem. 2007, 50, 6665-6672. 

---